Results 21 to 30 of about 47,406 (145)

The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study

open access: yesClinical and Experimental Obstetrics & Gynecology, 2022
Background: Genitourinary syndrome of menopause (GSM) majorly caused by the physiological decline in estrogen, affects up to 90% of menopausal women.
Violante Di Donato   +10 more
doaj   +1 more source

Genitourinary Syndrome of Menopause Assessment Tools [PDF]

open access: yesJournal of Mid-life Health, 2021
New therapeutic options are being considered to treat genitourinary syndrome of menopause (GSM), such as vaginal laser, ospemifene, or prasterone, but there is no explicit agreement in the scientific community for its use. Some concerns have arisen on how to evaluate the improvement of GSM symptoms.
Mension Coll, Eduard   +8 more
openaire   +3 more sources

A Diagnosis Not to Miss: A Case of Fitz-Hugh-Curtis Syndrome

open access: yesCase Reports in Infectious Diseases, 2022
Fitz-Hugh-Curtis syndrome is a rare disease attributed to complications of pelvic inflammatory disease secondary to chlamydia or gonorrhea infections.
Jenny Choy   +4 more
doaj   +1 more source

Pelvic floor muscle training associated with the photobiomodulation therapy for women affected by the genitourinary syndrome of menopause: a study protocol [PDF]

open access: yesPeerJ
Background Frequently, the women affected by the genitourinary syndrome of menopause experience genitourinary dysfunctions that profoundly influence their overall health.
Lívia Oliveira Bezerra   +5 more
doaj   +2 more sources

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats

open access: yesFrontiers in Endocrinology, 2023
IntroductionVulvovaginal atrophy (VVA) is a common condition in post-menopausal women. Symptoms of VVA include dyspareunia, vaginal dryness, vaginal and/or vulvar itching, burning and soreness, dysuria and vaginal bleeding accompanying sexual activity ...
Nur Hilwani Ismail   +7 more
doaj   +1 more source

Pallister-Hall syndrome presenting as an intrauterine fetal demise at 39 weeks′ gestation

open access: yesIndian Journal of Pathology and Microbiology, 2012
Pallister-Hall syndrome (PHS) is a pleiotropic autosomal-dominant malformation syndrome rarely presenting with genitourinary malformations. Literature has recorded 14 cases of PHS with genitourinary findings out of which only six have been females ...
Sunil Jaiman   +3 more
doaj   +1 more source

Impact of Genitourinary Syndrome of Menopause on Wellbeing, Functioning and Quality Of Life in Postmenopausal Women: A Cross Sectional Survey

open access: yesPakistan Armed Forces Medical Journal
Objective: To assess the impact of genitourinary syndrome of menopause on well-being, functioning and quality of life (QoL) in postmenopausal women. Study Design: Cross-sectional survey.
Asma Batool   +3 more
doaj   +1 more source

Current antimicrobial therapy of infectious complications of genitourinary syndrome in perimenopausal women

open access: yesРепродуктивная эндокринология, 2019
Genitourinary menopausal syndrome is characterized by urogenital and sexual symptoms (vaginal dryness and itching, urinary incontinence, dyspareunia, anorgasmia).
О. О. Єфіменко   +2 more
doaj   +1 more source

Efficiency of treatment and diagnostic algorithms in the rehabilitation program of women after hysterectomy with opportunist salpingectomy due to uterine myoma

open access: yesРепродуктивная эндокринология, 2022
Objectives: to determine the effectiveness of the rehabilitation program in women of reproductive age with uterine fibroids for correction of genitourinary syndrome after hysterectomy with opportunistic salpingectomy. Materials and methods.
O.M. Proshchenko, I.B. Ventskivska
doaj   +1 more source

ESTRIOL IN THERAPY OF VARIOUS GYNECOLOGICAL DISEASES

open access: yesМедицинский совет, 2017
Estriol is an effective and safe drug to treat climacteric syndrome, genitourinary syndrome, in a complex therapy of genital organs prolapsed, atrophic processes at the menopause stage, hypoestrogenia, at cervical factor of infertility.
V. N. Prilepskaya, E. G. Nazarenko
doaj   +1 more source

Home - About - Disclaimer - Privacy